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Bylaws are an important, vibrant
document that both bind and build us as a
medical staff. They are written by us, the
practicing physicians of the medical staff,
usually with input from Troika and the
Department Chairs, but only after many
revisions and debate from Division
Chiefs, and the body of physicians they
represent. They are, in the end, imperfect
documents like the people who create
them. The final language of any Bylaws
change is reviewed by a practicing
physician dominant Bylaws Committee,
legal counsel for physicians, and then
sent to the Medical Executive Committee
before coming to the main body of the
Medical Staff for final debate and vote.
The recent proposed changes of the
medical staff categories were the product
oftwo years ofthinking and multiple
iterations. Unanimously approved by the
Medical Executive Committee, the
Department of Medicine Executive
Committee, Surgical Execufive
Committee, and the Bylaws Committee,
these changes were also approved by
sweeping majority vote at the
Departments ofMedicine, Surgery,
Obstetrics and Gynecology, Pediatrics,
Family Practice, and Psychiatry. Then, at
the March quarterly meeting of the
general medical staff, these changes were
soundly defeated.
Since that staff meeting, I have received
dozens of letters and phone messages
from physicians informing me that this
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vote reflected more the voice of Populist
fervor than general disagreement with the
principle issues before the assembly.
Only time and deliberation will prove or
deny this sentiment. As concluded at the
meeting, I will encourage the Chairs to
bring further debate to their members, to
meet with the Chiefs of their Divisions
and Sections and further deliberate the
consensus of their department, for the
issues on the table remain unsolved but
solvable. In the end, these are OUR
bylaws. They need to be thoroughly
understood and approved by the working
majority here and any changes should be
embraced as necessary for the vibrant
good of the physician staff as a whole.
For the sake of clarity, let me charge
these meetings with the challenges at
hand:
I. As we bring voice, vote, and economic
accountability to Division and
Department meetings, it will be
increasingly important to define ourselves
as Active staff. Decide what minimum
level of activity should be required for an
Active staff physician to retain the
privilege of voice and vote at department
meetings and to assure that already
credentialed members remain in good
standing in practice of patient care.
2. For Courtesy staff, decide if there
remains a need for this category for every
Division and Department of the hospital
medical staff, and where it is needed,
whether activity in this class should be
delineated. Currently, this category limits
maximum number of patient contacts*,
(Continued on Page 2)
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not subject to the appeals process, but
does not address minimum number of
contacts to assure quality standards. For
surgery, for example, the department
recommended a minimum number of six
operations per year, not subject to appeal,
to remain vibrant in this category. Keep
in min.d that QA and credentialing remain
the very reason we gather together as an
organized medical staff and that this
·
process should be driven and directed by
physicians, not managed care companies
for business administrators. We have all
heard the argument that numbers of
contacts alone do not equate to quality
and with this I think we can agree. On
the other hand, with no numbers, quality
cannot be judged, much less assured to
our patient population. Where there are
quality concerns in any category the fair
hearing process is currently guaranteed.
3. Decide a class and category for our
relationship with PennCARE affiliates.
Decide what privileges, rights and powers
physicians should have in this category
which fosters collaboration without
unfairly tipping the delicate balance of
resources and interactions with our
current staff.
4. Re-examine our current use of the fair
hearings policy as delineated in the
Medical StaffBylaws and determine if it
is indeed a fair process (see attached).
. We have made no recommendations to
change it to date. Originally designed
and currently in use over 20 years, this
appeals process was created to protect the
rights of physicians who were called to
lose privileges because of quality
concerns. It is not currently called into
play for physicians who wish to exceed or
fall short of current activity levels
recommended for a category as these
activity levels were designed to be
minimal standards. If, for example, you
decided that Courtesy staff should have

no more than 12 contacts (defined below)
in Medicine, should physicians who wish
to exceed this without becoming Active
staff be recommended to the fair hearings
process? Should physicians in the
Courtesy category with essentially no
activity here in medicine (i.e. Jess than
one patient contact per year) be
recommended to appeal or simply moved
to the Referring level of activity? We
have supported the fair hearing process
for issues of quality not for issues of
simple category designation.
We welcome your suggestions through
the Chief and Chair meetings, through
personal communication or by voice mail
on the 402-DOCS hotline.
Lastly, let us open debate on the issue of
the Staff Development Plan in general.
We will do this at the April meeting of
the Medical Staff/Administrative
Exchange session and hold future debate
and discussion if there is a will to do so.
This plan was designed to allow
measured growth of our medical staff in
an equitable way which meets the
community needs and does not tip the
delicate balance of hospital resources.
Without it, unlimited and unrestrained
growth in every specialty and
subspecialtY would be permitted,
controlled only by the limits placed on
practices through internal competition.
Let's open debate on the two alternatives,
and deliberate on which is best for the
community of patients and physicians this
hospital serves.

)

John E. Castaldo, MD
President, Medical Staff
*The tenn "patient contact" means the
provision by a Medical Staff member of a
History and Physical Examination, or
provision of a consultation, or an admission of
a patient to the Hospital.
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1995 Physician Survey Helps LVHHN Identify
Successes, Problems
Despite a myriad of issues and changes
currently challenging health care
providers, Lehigh Valley Hospital and
Health Network's Medical Staff is
"generally pretty pleased with the
services of Lehigh Valley Hospital and
Health Network," says John E. Castaldo,'
MD, Medical Staff President. He bases
his observation on the results ofthe 1995 ·
physician survey, which he calls a "good
barometer" to identify successes and
problem areas at LVHHN. The 157
physicians who completed the survey
gave LVfrn.N an overall score of 4, with
a rating ofS equating to "excellent."

)

taking care of our community," said
Louis Liebhaber, Chief Operating
Officer. "The high level of physician
satisfaction results from serious attention
by the rest of the LVHHN team members
to providing high-quality patient- and
physician-friendly care."
Following are the highlights of the survey
results:

Twenty-one percent of the 750 Medical
Staff members completed the four-page,
I 08-item questionnaire in December. In
1994, the first year it was conducted, 140
doctors filled out the survey, which had
an overall average of3.919. Both ofthe
surveys were sponsored by Medical Staff
Services.

The Cardiac Catheterization Lab repeated
this year as the survey's number one
"Clinical" area. For this honor, Bret
Bissey, Administrative Director,
Department of Medicine, credits the cath
lab's "excellent physician leaders and
dedicated staff who strive to provide
outstanding customer satisfaction."
According to Mr. Bissey, further
improvements, initiated in March, include
the redesign of processes to reduce
patient waiting time and increase
procedure room use.

The respondents rated clinical and
administration in 33 programs and
services and· in anesthesia, emergency,
imaging, and pathology services.
Nursing care and management on patient
care units were also measured; and
outpatient, support, and edu~ation
programs \vere rated for general
satisfaction.

Gary Marshall, Oncology Administrator,
said he is pleased by oncology services'
leap forward from number 20 to seven. "I
think this reflects the continuous
improvement process by the Morgan
Cancer Center management and staff in
trying to understand and satisfy the needs
of the patients and physicians we serve,"
Mr. Marshall said.

"This is an opportunity for our Medical
Staff to contribute to change, to learn
trom the successes, and to improve areas
not doing well," Dr. Castaldo said. "This
information will be used to make the
hospital a better place."

Radiation Therapy ranked number two
this year, and the GI/Endoscopy Lab
placed third for the second time. In
addition, Outpatient Pediatrics moved up
I 0 places, from 22 to 12.

"I hope that our Medical Staff
understands that even in these turbulent
times, L VffiiN is focused on making our
services the first choice of physicians

The Open Heart Unit (OHU) rated first in
the "Nursing Units" category, moving up
from second place in 1994. Geary
Yeisley, MD, OHU Medical Director,
(Continued on Page 4)
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links this achievement to "the nursing
staffs first-rate technical skills and
collaborative spirit, and the strong
leadership of Kathleen Sullivan, Director,
Patient Care Services, OHU/TOHU.
The first unit to implement patient
centered care -- 7A -- showed the greatest
improvement, placing 12th in 1995
compared to 31st in 1994. Dr. Castaldo'
believes this advance reflects doctors'
acceptance and the benefits of patient
centered care.
Under the heading "Programs, Patient
Administration, Physician Services,"
Biomedical Photography and Lehigh
Valley Hospice ranked first and second,
respectively, both repeating from 1994.
Patient Education advanced from 21 in
the first year to seven in 1995, and O.R.
Scheduling moved up 10 slots to 21.
Patient ed specialist, Deb McGeehin,
believes that improved collaboration
through patient centered care, and efforts
to achieve consistent discharge
instructions and better documentation of
patient teaching have helped throughout
the hospital.

The O.R. Scheduling staffwas praised for
its progress by Herbert "Chuck" Hoover,
MD, Chairperson, Department of
Surgery: "They have made remarkable
improvements by streamlining the
scheduling process and now work more
closely with medical office staffs to better
accommodate both patients and
physicians."
Lehigh Magnetic Imaging Center placed
first, and anesthesia at the Fairgrounds
Surgical Center placed second in the
"Anesthesia, Emergency Services,
Imaging, Pathology Services" division of
the survey, duplicating their 1994
rankings.
Each department will receive its survey
results. Dr. Castaldo believes that
constructive feedback will lead to
improvements throughout the network.
"We need to praise the best departments
and encourage them to continue their
excellent work. The a.reas needing
improvement will be supported in their
efforts, and the lessons from the top
performers will be shared to help improve
the hospital," he said.

HIV Antigen Testing of Donor Blood (P-24)
Beginning the week of March 18, Miller
Mem'orial Blood Center began testing
donor blood with a newly approved test
required for donor testing called the HIV
P-24 Antigen Test. This testing
supplements current testing and is
positive earlier in infection reducing the
"window phase" when a person is
infected by HIV but not positive by
laboratory methods from 24-26 days to
approximately 16 days. The risk of HIV
infection from blood transfusion has
recently been reviewed and current
estimates of risk are from 1:440,000 to

1:640,000 or approximately 1 in 500,000
transfused units. Locally, of
approximately 83,000 donors screened in
the last 18 months by the currently
employed antibody test, only two were
positive for antibody to HIV and those
donations were discarded. Thus, the
incidence ofHIV antibody in the local
donor pool is very low and hence so is the
risk ofHIV transmission. It is estimated
that nationwide the new test will identify
about seven cases of early HIV infection
(Continued on Page 5)
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among donors. The cost is about $50
million annually. The cost per quality
adjusted life years is estimated to be $2.3
million.
It is the intention of the Blood Center to
comply with a January 6, 1996 American
Association of Blood Banks Bulletin to
begin testing. During the transition
period during which the inventory of the'
Blood Center is being tested, the AABB
has recommended that each hospital and
its Medical Staff establish a mechanism
to address relevant transfusion practice
issues. These Include minimizing the
number of transfusions during the
transition phase (as long as a week) and
in the cast of surgeries requiring
transfusion, discussion with potential
recipients about the test and the safety of
the blood supply.
Talking points to aid the discussion with
potential recipients during the consent
process include:

• With current testing methods, the risk of
HIV infection from transfusion is
approximately I :500,000.
• The addition of the P-24 antigen test is
estimated to identify nationwide seven
donations that would not be detected
otherwise each year.
• Locally, the risk ofHIV transmission
from blood is low because the number of
units positive for antibody is low and hence
the prevalence of HIV in the donor
population is low compared to other areas
of the country.
• Regardless of how small, there is always
a risk with allogeneic transfusion and the
safest product is autologous when this is an
option. Autologous donations are available
at the Cedar Crest campus and can be ·
arranged by called 402-0650.
If you have any questions regarding this
issue, please contact Bala Carver, MD,
Medical Director, Transfusion Medicine
& HLA Lab, 402-8142, or David
Beckwith, PhD, Vice President,
Operations, and Clinical Director, Health
Network Laboratories; 402-8150.

News from Infection Control
C. Difficile Alert
Since the discovery ofC difficile as the
etiologic agent of antibiotic-associated
pseudo membranous colitis in 1978, a
great deal has been learned about the
pathogenesis, clinical manifestations,
diagnosis, and epidemiology of this
ubiquitous nosocomial pathogen. Despite
this understanding, prevention and
control of C difficile infections has been
difficult.
C difficile-associated diarrhea and colitis
continues to be a MAJOR problem in our
hospital.
C difficile is the most important
identifiable cause ofNOSOCOMIAL

infectious diarrhea in this country.
Although the most common clinical
manifestation of C difficile infection is
diarrhea, the disease spectrum ranges
from asymptomatic colonization or fecal
excretion to pseudo membranous colitis
(PMC) to TOXIC MEGACOLON, which
may present with signs of an acute
abdomen but WITHOUT diarrhea. Toxic
megacolon is an important syndrome to
recognize as it is associated with a high
mortality rate and frequently requires
surgical intervention.
Symptoms of C difficile may consist of
only a few loose stools per day or
multiple, large-volume, watery stools and
(Continued on Page 6)
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signs of dehydration. Stools may have
mucus or evidence of occult blood. In
addition, a distinct fecal odor is often
recognized. Other symptoms may
include abdominal pain, ileus, fever, and
leukocytosis.
As noted earlier, there has been an
INCREASE in the number of C difficile
cases within our institution. It is
IMPERATIVE that we adhere to the
following Infection Control practices to
prevent transmission of nosocomial C
difficile-associated disease.
1. BARRIER PRECAUTIONS

Glove use when handling body
substances
Hand washing between patients
Isolation precautions and cohorting
2. ENVIRONMENTAL CLEANING
AND DISINFECTION
Patient rooms and bathrooms
Equipment and environmental surfaces
Bedside commodes
3. IDENTIFICATION AND
MANAGEMENT OF ASYMPTOMATIC
CARRIERS
4. MEASURES TO REDUCE THE
RISK OF SYMPTOMATIC DISEASE
Antimicrobial use restriction
No single infection control practice alone
can effectively prevent or control
nosocomial C difficile infections.
However, a combination of the practices
together can MAKE A DIFFERENCE.
Likewise C difficile is NOT the problem
of just ONE patient care area, rather it is a
problem that must be addressed by ALL
PATIENT CARE AREAS.
All disciplines must work together to
combat this problem!

If you have any questions, please contact
Terry Burger in Infection Control at
402-0680.

VRE Precautions
Are we indeed on the horizon of what
certain alarmists are predicting as the
"post-antimicrobial era?" In recent years,
a growing number of organisms have
exhibited resistance to not only the old
guard antibiotics, but also to the latest
pharmacological concoctions being
released on the market. Vancomycin
resistant enterococcus (VRE) has been
declared one of the hottest emerging
pathogens having significant implications
as a nosocomial organism in the hospital
setting. Most alarming is the fact that
VRE exhibits multiple resistance to a host
of available antimicrobial agents with
only a few dim prospects remaining for
treatment.
The emergence of VRE along with a
number of other resistant organisms has
been attributed to the intensive use of
antimicrobials and the failure to
consistently apply basic infection control
practices and procedures. A recent
consensus statement made in JAMA,
(January 17, 1996- Vol. 275, No.3, pgs.
234-240) calls for a multidisciplinary,
systems-oriented approach to address the
current crisis we are experiencing due to
the rising incidence and spread of
resistant organisms. The statement was
made by a group of experts from hospital .
epidemiology and infection control,
infectious diseases, clinical practice,
pharmacy, administration, quality
improvement, medical informatics, and
outcomes. The group was challenged
with the task to provide hospital leaders
with "strategies to prevent and control the
emergence and spread of antimicrobialresistant microorganisms in hospitals."
.(Continued on Page 7)
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The contributors to the consensus
statement developed strategic goals to
guide hospitals in the fight against the
rising resistance of microorganisms. The
goals were directed toward creating
delivery systems to optimize
antimicrobial use and establishing
methods to detect, report and prevent the
transmission of antimicrobial resistant
organisms. One of the goals
recommended that hospitals develop a
plan for discharging, and readmitting
patients colonized with specific
antimicrobial resistant pathogens.
The Centers for Disease Control also
recognizes that aggressive infection
control measures must be undertaken to
reduce the nosocomial spread of VRE.
Since patients with VRE may remain
colonized with the organism for long
periods following discharge, the CDC
recommends a system be in place to
highlight the records of these patients so

they will promptly be placed in isolation
if readmitted. In an attempt to comply
with the recommendations from the CDC
published in the MMWR, the Infection
Control Department has found it
necessary to develop a process which
would flag patients in our computer
system who have been identified with
VRE. Upon readmission, the VRE
patient will then be directly placed on the
·appropriate isolation precautions.
Effective March 1, the Infection Control
Department began the process of
highlighting patient records with VRE
infections. Should the patient be
readmitted in the future, their pre-admit
screen will indicate that they must be
admitted into a private room under
isolation precautions.
If you have any questions or comments
regarding this new process, please contact
Terry Burger in the Infection Control
Department at 402-0680.

News from the County Medical Society
Over 2, 700 physicians, their families, and
their staff signed up to come to
Harrisburg to participate in the Tort
Reform Rally originally scheduled for
January 23, 1996. As you may be aware,
the rally had to be postponed due to the
state-wide flood emergency that occurred
just prior to the 23rd. The rally has now
been rescheduled for May 7, but we need
your help to rekindle the enthusiasm that
had been created during the planning
process for the earlier one.
For planning purposes, below is the
preliminary schedule for the rally. All
times are approximate.
10 to 10:30 a.m.- Arrive in Harrisburg
11 a.m. - Pre-rally/Box lunch
Noon to 1 p.m. - Travel to Capitol

1 to 2 p.m. - Rally
2 to 3 p.m. - Visit Legislators
3:30p.m.- Depart for Home
Please make every effort to be present or
have your practice represented at this
very important event for the future of
medicine in Pennsylvania!
Contact Lou Eister at the Lehigh County
Medical Society at 437-2288 to confirm a
reservation and/or arrange bus
transportation.
Robert X. Murphy, Jr., MD
Chairman, Legislative Committee
Lehigh County Medical Society
and
HMSS Representative
Lehigh Valley Hospital
Page 7

Incentive Program Rewards Cost-Saving Ideas
Want to win a free trip, a new TV or stereo, or
maybe a new set of golf clubs? A new
operations improvement (01) incentive
program to be launched this spring at Lehigh
Valley Hospital and Health Network
(L VHHN) will award merchandise, vacations,
and cash to employees, physicians, volunteers,
and auxiliary members who provide valuable
OI ideas.
Beginning in May, individuals and teams can
help LVHHN become a more cost-effective
health provider and earn great prizes. And if
LVHHN's FY '96 01 goal of $20 million is
reached, all incentive program winners will
receive bonus prizes.
The 01 incentive program will provide the
energy to "jump-start" the cost-savings
efforts, according to Lou Liebhaber, COO.
"To be a true success, the OI program must
have the help of the more than 4,000 people
who work or volunteer here each day," he
said. As of the end of February, more than
$8.4 million of this fiscal year's $20 million
OI goal has been achieved.
The program will be launched in May at
meetings around the clock. Coaches and other
resource personnel, recruited from middle
management, will explain the rules and
reward structures and distribute the materials
needed to participate in the program. They
will work with groups that want to propose 01
projects. Each attendee who signs up for the
program at the launch will receive a free gift
bearing the LVHHN logo.

In addition to rewards for suggesting 01
projects, the person or team providing the idea
with the highest cost-savings value each
quarter will receive a special prize. It could
be a trip, cash, or another form of reward.
Jim Burke, Vice President, will lead
LVHHN's 01 incentive efforts. He will be
assisted in the necessary development, launch,
and operation of the program by the BI
Employee Performance Group of
Minneapolis. According to Mr. Burke, BI has
a proven track record for helping
organizations rally their members to reduce
costs. "They have had tremendous success
with hospitals and companies nationwide. In
Philadelphia, they've helped Pennsylvania
Hospital, Jefferson, and the Hospital of the
University of Pennsylvania save millions of
dollars." BI will be involved in setting the
program rules, training coaches and other
resource personnel from the network, and
providing reference and "how-to" materials.
Their compensation will be based on a
percentage of the total 01 savings.
If you have any questions or comments
regarding this program, please contact Jim
Burke at 402-9790.

For Your Information
X A new card access lock has been
installed for the Medical Record Department
at 17th & Chew for your convenience.

The concept for the program was developed
by Lou Liebhaber with the input of a group of
employees and physicians who have been
working on the details since January.

During the hours when Medical Records is
closed (Monday through Friday - midnight to
7 a.m., and Saturday, Sunday, and holidays
- 3:30 p.m. to 7 a.m. the following morning),
you may use your 1.0. badge for access.

"This program will be fun and rewarding, and
help LVHHN improve its competitive position
in the local health care marketplace," Mr.
Liebhaber said. "Many employees have
suggested an incentive program to help us
involve more people. To succeed, we must
rely on our colleagues to identify 01
opportunities in their daily work."

X The Email department name has been
changed from SA Med/Surg to Trans
Trauma Unit. A new public mailing list has
also been created to reflect the name
change. The mailing list name is:
/Trans_Trauma_Unit
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L VHHN Continues to Respond to Trends
Lehigh Valley Hospital and Health
Network (L VHHN) continually evaluates
the impact of daily inpatient census
trends, program changes, and
construction. Beds were recently closed
on several patient care units at Cedar
Crest & 1-78.

)

The hospital is currently licensed for 842
beds (including 52 skilled nursing beds),
and 679 are staffed. The decreasing
inpatient census at L VH and relocation of
day-of-procedure-admission (DOPA)
beds from 3C resulted in the closing of 10
beds on 4A, reducing the registered
nursing staffby 5.3 FTEs and nursing
technical assistant FTEs by 1.4, according
to Terry Capuano, Administrator, Patient
Care Services. Displaced employees are
receiving support from the network in
their efforts to find new positions.
Moving the DOPA beds to 4A made
room for the redesign of the invasive
cardiology area, formerly the Cardiac
Cath Lab and 3C.
A special four-bed room was built on 4A
to enhance the continuity of care of

vascular surgery patients, who can now
be discharged sooner, according to Jane
Barbe, Patient Care Director, 4A and 4C.
Fourteen beds were recently closed on SA
(transitional trauma) to make room for a
physical therapy gym and accommodate
renovations for patient centered care,
according to Marilyn Guidi, RN, Patient
Care Director, SA and Shock/Trauma
Unit. Five employees have been
displaced through this process.
"Because of the impact of managed care
on admissions, we must adjust our
number of inpatient beds to match the
hospital's needs, Mrs. Guidi said.
According to Mary Kinneman, Senior
Vice President, Patient Care Services, the
current approach to trimming operations
in response to the falling census provides
two opportunities for improvements.
"Closing only part of a unit allows us to
save on personnel costs and convert
clinical space into support and storage
areas."

Cardiac Cath Lab Redesign
Implemention of the redesign of the
Invasive Cardiology Area, formerly the
Cardiac Catheterization Lab and 3C,
occurred on March 4. The redesign is the
result of a collaborative effort of
administration, physicians, and clinical
staff that began a little over a year ago
and is rooted in the patient centered care
philosophy.
·

)

The goal of the Invasive Cardiology Area
is to provide the highest level of care and
the best patient outcomes at the lowest
unit cost. Major objectives of the
redesign include:

• Decreased patient waiting time
• Increased room utilization
• Minimization of overtime expenses
• Establishment of a cost-competitive
market
• Increased capacity for future patient
volume
From an operational perspective,
implementation of the redesign will
bring:
·
• A dedicated electrophysiology program
(Continued on Page 10)
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• New scheduling guidelines and
improved tum around efficiencies in the
Cardiac Cath Lab area
• Integrated documentation systems
• Revised CareMaps for each patient
type
• Changes in skill mix and cross training
in all areas
• The dedication of the former 3C area to
the care of Cardiac Cath Lab patients.
All outpatients and inpatients having a
Cardiac Cath Lab procedure will remain
on 3C for their post procedure care up to
a 24 hour periqd. After 24 hours, an
evaluation of the patient's needs will
occur to determine appropriate patient

placement. The 3C area will be
operational Mondays at 6 a.m. through
Saturdays at 3:30p.m.
• Plac·ement of inpatients formerly on 3C
on other patient care areas; movement of
inpatients formerly on other critical care
units post Cardiac Cath Lab procedure to
3C
• Movement of DOPA to 4A

If you have any questions or comments
regarding the redesign of the Invasive
Cardiology Area, please contact Robert
Oriel, MD, Medical Director, Cardiac
Catheterization Lab; or Julie Clelland or
Bob Baumgartner, Co-Directors, Invasive
Cardiology, at 402-8660.

News from the Center for Educational Development & Support
Category 2 CME
All physicians in Pennsylvania must
participate in Continuing Medical
Education (CME) activities sufficient to
(a) fulfill the requirements of the AMA
Physician's Recognition Award (PRA), or
(b) fulfill the requirements of the
Pennsylvania Medical Society. These
requirements are slightly different, but
each require participation in a minimum
of 50 hours of CME each year, of which
up to 30 hours may be designated
Category 2.
•

Only organizations accredited to give
Category 1 credit (Lehigh Valley Area
Health Education Center) can authorize
programs to advertise which programs
fulfill the requirements for Category 2
credit.
Physicians are responsible for cataloging
their own Category 2 activities.
Questions or concerns can be directed to
Jennie Hower in the Center for Education
at 402-5243.

When you need
to talk ...
help is just a
phone call away.

PiliZIIIIII!!!II.-

Category 2 CME activities include
clinical consultations contributing to the
physicians education, QA/QC activities,
teaching, journal clubs, self assessment
examinations and reviews, computer
based learning activities, journal or book
publications, or attending programs
designated as acceptable for Category 2
education. Reading medical journals is
not an acceptable activity for Category 2
designation; it is assumed that all
physicians read the medical literature
regularly.

Physician Assistance
Program
To arrange a confidential
appointment or for more
· information, call
(61 0) 433-8550 or

1-800-327-8878.
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Penn CARE Partnership Marks Key Developments
Two important developments for
PennCARE signal increased momentum
for the health partnership of physicians
and eight hospitals that first organized in
May 1995.
First, the network has officially been
incorporated in the Commonwealth of
Pennsylvania, a move that now allows
PennCARE to enter into contractual
arrangements with insurance companies
on behalf of participating hospitals and
physicians. Second, PennCARE signed
the first ofthose contractual
arrangements, a long-term agreement
with U.S. Healthcare, the region's largest
health maintenance organization (HMO).
Negotiations with other major insurers
are also under way.
"This is compelling evidence of our
collective intent to create a market
presence that is both powerful and
lasting," said Elliot J. Sussman, MD,
LVHHN President and CEO, and
Chairman of the Board and President for
PennCARE. "But more important, it is an
acknowledgment to the people we serve
that accessibility to high-quality, costeffective care is key to our communities'
well-being."
PennCARE's incorporation, coupled with
the U.S. Healthcare contract, creates in
effect the region's first health network to
blend the financing and delivery of health
care, by bringing physicians, hospitals,
and insurance companies together in a
single entity, according to Thomas H.
Hansen, Senior Vice President, Lehigh
Valley Health Services Division. Mr.
Hansen has been principally involved in
the U.S. Healthcare negotiations and was
recently elected secretary of the Board of
Directors for PennCARE.

hospital partners in PennCARE to
improve health care delivery, lower costs,
and generally enhance the health of
groups that enroll, said Mr. Hansen.
"Everyone benefits in that kind of system.
And employers who opt to offer network
plans choose the best mechanism
available to control their health care
costs."
Additional LVIDIN representatives on
the Penn CARE Board of Directors
include Joseph A. Candia, MD, and John
Jaffe, MD. Both are also on the executive
committee.
Other PennCARE hospital members
include: Doylestown Hospital, Gnaden
Huetten Memorial Hospital in Lehighton.
Grand View Hospital in Sellersville,
Hazleton General Hospital, Hazleton-St.
Joseph Medical Center, Muhlenberg
Hospital Center in Bethlehem, and North
Penn Hospital in Lansdale. Penn State
University's Hershey Medical Center will
participate through a contract for highly
specialized medical services.
The medical staffs of the hospitals
represent 2,230 physicians. The eight
hospitals have a total of 1,877 beds, with
more than 68,000 inpatient admissions
and more than 822,000 outpatient visits in
1994.

"This kind of network integration creates
tremendous incentives for physician and
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Library News
17th & Chew Library Relocates
Visit the Library in its newly renovated
headquarters on the ground floor across the
hall from the Medical Record Department.
This Library, in its new location, will continue
to provide essential resources to support the
services at 17th & Chew. In addition, a new
service-- a World Wide Web connection with
full graphics capabilities -- has been added.
As a convenience to beginner "web crawlers,"
a select number of home pages will be easily
accessible through menu options. The Library
also has a directory of listings for many other
medical-related web sites.
The new Library has a separate reading room
which houses the current journal issues, the
reference collection, and a computer for
searching OVID.
Some minor modifications have been made to
the book and journal collections. The general
history of medicine collection (excluding the
Classics in Obstetrics, Gynecology, and
Psychiatry) and the medical ethics collection

have been transferred to the Cedar Crest &
1-78 Library. The hospital's Historical
Archives and the School of Nursing Alumni
have provided homes for many of the old
textbooks.
A few backfiles of journals have been
transferred to the Cedar Crest & 1-78 Library,
and some are being temporarily stored. There
will be no change in the journal titles offered.
As always, inter-library loan services will be
provided for materials not owned by either of
the hospital's libraries.
Chad Carver has been very instrumental in the
design of this new facility. Most of the
furnishings from the old location have been
reused to minimize the cost of the
renovations. Please stop by to say "hi" and
"thanks" for a job well done.

New Acquisition
The following textbook was recently acquired
at both library locations:
Noble, Young, et al. Textbook of Primary
Care. 2nd ed. Mosby, ·1996.

)

TV Show to Feature Morgan Cancer Center
WLVT-TV-39 will spotlight the John and
Dorothy Morgan Cancer Center in a program
on home care for cancer patients on April23,
at 3 and 7:30 p.m. The show will feature the
Family Caregiver Cancer Education Program
(FCCEP), sponsored by the Pennsylvania
Department of Health's Cancer Control
Program. Because of the increased need for
quality home care for cancer patients, the
Department of Health implemented the
FCCEP at four medical institutions, including
LVH.
Representatives from the Cancer Center
appearing on the show will include Lorraine
Gyauch, Director of the Family Caregiver
Cancer Education Program; Louisa Weber,
the bilingual oncology social work educator;
and Therese Gyauch, Program Coordinator
for Latino Outreach for FCCEP.

As the time allotted for inpatient cancer care
decreases, outpatient care must grow stronger.
Often, however, caregivers must assume roles
for which they are unprepared, both
physically and emotionally. This places an
additional strain on families and loved ones.
The FCCEP offers education and support for
patients and caregivers, thereby increasing the
quality of life for all those involved.
Resources available include the publication
"Helping People Cope: A Guide for Families
Facing Cancer," free through the Department
ofHealth's toll-free phone number 1-800-PACANCER, and the Latino outreach effort,
which shares the FCCEP services with the
Latino community through a Family
Caregiver course delivered in Spanish.

)
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Stepping Out...
MSWalk

WalkAmerica

Did you know that about 300,000
Americans suffer from multiple sclerosis
(MS) and that it is the most common
central nervous system disease of young
adults in the United States? These are
startling facts.

WalkAmerica, the annual fundraiser of
the March of Dimes, is the nation's
biggest walking event with over 1,400
communities taking part nationally -- and
it's coming to Allentown on Sunday,
April28. The March ofDimes supports
programs of research, community
services, advocacy and public and
professional health education to give
more babies a healthy start in life.

Fortunately, the MS Society is dedicated
to advancing the cure, prevention and
treatment of MS and to improving the
lives of those affected by this devastating
disease. You and your family can help in
these efforts by participating in the 1996
MS Walk.
The MS Walk is an exciting annual event.
The benefits to participating are
enormous. First, and most importantly,
your pledges go to work right here in the
Lehigh Valley helping those who suffer
from MS. Team-building events, like the
MS Walk, generate positive enthusiasm
among employees. They build morale
and increase the sense of teamwork
within the organization. And the MS
Society recognizes teams for their efforts
by giving prizes and awards to the top
· achievers.
In 1995, Lehigh Valley Hospital won the
award for "Best Rookie Team." Last
year, more than 1,200 people on 50
different teams from throughout the
Lehigh Valley walked to raise more than
$60,000 for medical research and support
groups.
This.year's 6-mile MS Walk will be held
on Sunday, April 14, beginning at 8:30
a.m., at the Muhlenberg Field House.
Sign up now and join Alex Rae-Grant,
MD, Lehigh Valley Hospital's Team
Captain, in this very worthwhile event.

)

Believe it or not, the infant mortality rate
in the United States is worse than 23
other nations. Every two minutes, a low
birthweight baby is born. Every hour, a
baby dies due to a birth defect. In fact,
one in five babies will die from a birth
defect. Thanks to the efforts of the
March ofDimes, thousands of families
will be spared this tragedy.
Our community and local hospitals
benefit from WalkAmerica. Over the
past 15 years, Lehigh Valley Hospital has
received more than $325,000 in grants
from the March of Dimes. In tum, we
educate our patients and the community
on maternal and child health and care for
premature and sick infants using the latest
technology.
Lehigh Valley Hospital is organizing a
team for WalkAmerica headed by James
Balducci, MD, Chief of the Division of
Obstetrics and Section of Maternal-Fetal
Medicine. Teammates will receive aTshirt featuring the hospital logo and be
eligible to win a variety of fabulous
prizes. For more information or to
register, contact Fran Derhammer at 4022903, or Gail Pitsko at 402-3001 or
through e-mail.

For more information, contact Nancy
Eckert in Neurosciences Research at
402-9830 or through e-mail.
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Robin Roberts to Kick-Off Spirit of Women in Sports
Robin Roberts, sports commentator for
ESPN and ABC Sports, will be the
keynote speaker for the kick-off of Spirit
of Women in Sports, a first-time fitness
event on April 19 and 20. The event is
designed to encourage women of all ages
to learn the physical and emotional
benefits of involvement in sports.
Organized by Cedar Crest College and
Lehigh Valley Hospital in collaboration
with the Women's Sports Foundation-- a
national organization dedicated to
fighting inequalities in women's sports
funding -- and corporate and community
partners including The Bon-Ton, Spirit of
Women in Sports will be held on the
Cedar Crest College campus. The twoday event will begin with the first annual
G.O.A.L.S. (Girls and Women's
Opportunities for Achievement in Lehigh
Valley Sports) awards ceremony
honoring special achievements of the
valley's female athletes and coaches on
April 19 at 7 p.m. in Alumnae Hall
Auditorium. Saturday's activities, from
7:30a.m. to 12:15 p.m., will include a
health and fitness expo in the Thompkins
Center, and sports clinics in Lees Hall
and on campus athletic fields:
Ms. Roberts will open the G.O.A.L.S.
ceremony with an inspirational talk about
her experiences as a sports figure. This
event marks the first time that the
Women's Sports Foundation has
sponsored its national awards in the
Lehigh Valley. Grants supporting
women's involvement in sports will also
be awarded.
Saturday's health and fitness expo and
sports clinics are for females ages 8 and
up. The expo will provide information
from local experts on sports psychology,
nutrition, strength and flexibility training,
and Tai Chi. Health screenings will also
be available. Sports clinics conducted by

Lehigh Valley health and fitness
professionals will feature interactive
sessions on walking, running, weight
training, softball, volleyball, tennis,
basketball, and field hockey.
According to Patrice Weiss, MD,
Department of Obstetrics and
Gynecology, Spirit of Women in Sports
grew out of an idea of using role models
and developing a network among girls
and women that would promote their
participation in sports. "We are creating
a forum where girls and women can be
introduced to sports and fitness activities
by other women who have developed
expertise in these areas. That's what
makes Robin Roberts the ideal role model
for this event. She is not only an
established athlete, but also a hardworking professional who integrated her
enthusiasm for sports into her career and
paved the way for women in the field of
broadcast journalism," said Dr. Weiss.
Spirit of Women in Sports is part of the
ongoing initiatives of the Spirit of
Women partnership that began in 1993 as
a means of providing area women with a
forum for exchanging ideas about health,
work and family issues. Event organizers
decided to broaden these initial themes by
developing a program geared toward
women's fitness and wellness-factors that
can begin to shape one's quality of life
from an early age.
Registration for Spirit of Women in
Sports is now underway. The G.O.A.L.S.
awards ceremony with keynote speaker
Robin Roberts is free of charge. The cost
of the health and fitness expo and sports
clinics is $20 for adults and $1 0 for girls
under 18. A limited number of
scholarships are also available for the
event. For more information or to
register for Spirit of Women in Sports,
call 402-CARE.
Page 14
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Congratulations!
Andrew J. Pestcoe, DO, Division of
Otolaryngology, received notification
from the Bureau of Osteopathic
Specialists of the American Osteopathic
Association that they approved the
recommendation of the American
Osteopathic Board of Ophthalmology and
Otorhinolaryngology to certify him in .·
Otorhinolaryngology and Facial Plastic
Surgery.

Madhumati Raju, MD, Division of
General Internal Medicine, was notified
by the American Board of Internal
Medicine that she passed the certifying
examination and has now become
certified as a Diplomate in Internal
Medicine.

Papers, Publications and Presentations
Indru T. Khubchandani, MD, Division
of Colon and Rectal Surgery, was the
invited guest at the First Cuban Society of
Coloproctology in Havana, Cuba, from
February 12-14. The meeting was
inaugurated by the Minister of Health and
the Mayor of the City. Dr. Khubchandani
lectured on "Incontinence" and "Setting
Up Practice of Coloproctology." He was
awarded Honorary Fellowship to "La
Sociedad Cubana de Coloproctogia."
Robert Kricun, MD, Vice Chairperson,

Department of Radiology/Diagnostic
Medical Imaging, and Michael D.
Pasquale, MD, Chief, Division of
Surgical Critical Care, presented lectures
at the nursing Trauma Evening Seminar
on March 11. Dr. Kricun presented
"Radiology ofthe Chest in Trauma," and
Dr. Pasquale presented ''Nutrition in
Critical Illness."

Carol B. Laurenzano, PsyD,
psychologist, and David Mitchell, BSN,

RN, ofthe Department of Psychiatry, in
conjunction with Cecelia Grindel, PhD,
RN, formerly ofNursing Research, coauthored an article, "Sexual Abuse
Assessment on Admission by Nursing
Staff in General Hospital Psychiatric

Settings," which was published in the
February 1996 issue of Psychiatric
Services. The authors surveyed inpatient
psychiatric facilities nationwide and
found that although nurse managers
recognize the importance of including an
assessment of patients' history of sexual
abuse, there were several obstacles to
implementing this procedure.

Dominic P. Lu, DDS, Program Director,
General Practice Residency Program in
Dentistry, James F. Reed Ill, PhD,
Director, Department of Research, and
Gabriel P. Lu, MD, PhD, Assistant
Professor, General Anesthesiology,
Albert Einstein College of Medicine, coauthored a paper, "Safety, Efficacy, and
Acceptance of Intramuscular Sedation:
Assessment of 900 Dental Cases," which
was published in the November 1994
issue of Compendium. This paper was
the result of a joint research project
between Lehigh Valley Hospital's Dental
Department, Catholic Medical Center of
Brooklyn and Queens Department of
Dentistry - Canal University Medical
College, and the Albert Einstein College
of Medicine in New York.

(Continued on Page 16)
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Dr. Lu also authored "The Use of
Hypnosis for Smooth Sedation Induction
and Reduction ofPostoperative Violent
Emergencies from Anesthesia in Pediatric
Dental Patients," which was published in
the May-June 1994 issue ofthe Journal
ofDentistry for Children.
In addition, Dr. Lu and Elliot V. Hersh,
DMD, MS, PhD, Director, Pharmacology
& Clinical Therapeutics, University of
Pennsylvania, co-authored "Intra-Canal
Dissolution of Sargenti Paste," which was
published in the June/July 1994 issue of
The New York State Dental Journal.
This paper was the result of a joint
research project between Lehigh Valley
Hospital's Dental Department and the
University of Pennsylvania School of
Dental Medicine.
James C. Weis, MD, Division of
Orthopedic Surgery, presented a paper
titled, "In Vitro Biomechanical
Comparison of Multistand Cables to
Conventional Cervical Stabilization
Techniques," at the Cervical Spine
Research Society meeting in Santa Fe,
NM, in December.

In addition, Dr. Weis presented a
scientific exhibit titled, "Video Assisted
Thoracic Surgery- Diskectomy," at the
recent American Academy of
Orthopaedic Surgeons meeting in Atlanta,
Ga.
Two abstracts co-authored by Steven L.
Zelenkofske, DO, Division of
Cardiology, were accepted for
presentation at Cardiostim 96 which will
be held in Nice, France from June 19-22.
"A Prospective, Multi-Center Study
Demonstrating Clinical Benefit with a
New Accelerometer-Based DDDR
Pacemaker" was selected for an oral
presentation. "Heart Rate Variability in
Chronotropically Incompetent Patients
During a Prospective, Multi-Center
Study," was selected for a poster
presentation. Dr. Arnaud Lazarus, one of
the co-authors, wiii be the presenter for
both abstracts since he practices in
France.

Upcoming Seminars, Conferences and Meetings
April Forums Scheduled
In order to better facilitiate face-to-face
dialogue between senior management and
LVHHN employees and members ofthe
medical staff, a number of forums have
been scheduled for the end of the month.
The forums wiii provide an opportunity
for Lou Liebhaber, COO, to discuss the
recently announced $13 miilion work
force expense reduction effort with staff
and physicians. He will also field
questions and comments from those in
attendance.

Employees and medical staff members
are encouraged to attend one of the
following meetings:
Tuesday, April23 -Noon to 1 p.m., 17th
& Chew Auditorium
Thursday, April 25 - 2 to 3 p.m., I 7th &
Chew Auditorium
Friday, April 26 - 3 to 4 p.m., 2024
Lehigh Street
Monday, April 29 - 7 to 8 a.m., and 2 to 3
p.m., Cedar Crest & 1-78 Auditorium
(Continued on Page 17)
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Medical Staff/Administrative
Exchange Session
The next Medical Staff/Administrative
Exchange Session will be held on
Thursday, Aprill8, beginning at 5:30
p.m., in Conference Room 1 - Side B of

the John and Dorothy Morgan Cance~.
Center.
The topic for this session will include
staff development/manpower issues.

For more information, contact John E.
Castaldo, MD, Medical Staff President,
through Physician Relations at 402-9853.

Regional Symposium Series
Third Annual Current Trends in
Cancer Care: Prostate Cancer will be

held on Saturday, Aprill3, from 8 a.m. to
I :20 p.m., in the Auditorium at Cedar
Crest & 1-78.
Medical and radiation oncologists,
surgeons, urologists, internists, family
practitioners, nurses, radiation
technologists, and other health
professionals interested in current trends
in cancer care will benefit from this
program.
At the completion of this program,
participants should be able to:
• dispuss the role of combined modality
staging for clinically localized prostate
cancer
• discuss the role of hormone therapy in
the treatment of localized prostate cancer
• identify the role of chemotherapy in the
treatment of advanced prostate cancer
• identify the current treatment outcomes
for prostate cancer at Lehigh Valley
Hospital

• apply the theoretical discussion to
actual case presentation

Seventh Annual Pediatric Symposium:
The Pediatric Athlete will be held on

Thursday, April IS, from 12:40 to 5 p.m.,
in the Auditorium at Cedar Crest & 1-78.

Pediatricians, family practitioners,
psychiatrists, nurses, social workers,
teachers, and other health and education
professionals interested in pediatric
athletes will benefit from this program.
At the completion of the program,
participants should be able to:
• discuss the difference between the
child and the adult athlete from an
exercise perspective
• demonstrate appropriate types of
strength training for age of athlete
• describe diagnose and recommend
treatment for the various osteochondroses
• perform a pre-participation fitness
exam on the young athlete
• recognize the abnormal spine in the
youth who wishes to participate in sports
• examine.and diagnose abnormalities of
the knee, shoulder, elbow, ankle, and foot
For more information on these programs,
please contact the Center for Educational
Development and Support at 402-121 0.

Medical Grand Rounds
The Use of Calcium Channel Blockers
in the Treatment of Hypertension and
Renal Disease will be presented by
Howard Garfinkel, MD, Chief, Division
ofNephrology, Danbury Hospital, on
April9.
(Continued on Page 18)
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Newer Therapeutic Approaches in
the Elderly will be presented by

Harry Gavras, MD, Chief,
Hypertension & Atherosclerosis,
Boston University Medical Center, on
April16.

An Update on the Management of
Lupus Nephritis - Emphasizing
Long Term Side Effects will be

presented by W. Joseph McCline, MD,
Associate Chief of Clinical Activities,
Division of Rheumatology, University
of Michigan, on April 23.

Osteoporosis - Guidelines for
Therapy for the Practicing
Physician will be presented by Melvin
Horwith, MD, Division of
Endocrinology, Penn State UniversityHershey Medical Center, on April 30.

Department of Pediatrics
HIV and AIDS Infection in
Children & Adolescents will be

presented by Richard M. Rutstein,
MD, Children's Hospital of
Philadelphia, on April 12.

Update on the Treatment of
Nephrotic Syndrome in ~hildren
will be presented by Steven Wassner,

MD, Chief, Division of Pediatric
Nephrology, Hershey Medical Center,
on April26.
The above conferences will be held at
noon in the hospital Auditorium at
17th & Chew. For more information
on the Pediatric conferences, please
contact Cindy Williams at 402-2536.

Medical Grand Rounds are held from
noon to 1 p.m., in the Auditorium at
Cedar Crest & 1-78. For more
information, please contact the
Department of Medicine at 402-8200.
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Who's New
Medical Staff
Appointments
Dean A. Ruble, DO
Whitehall Medical Center
1250 Schadt Avenue
Whitehall, PA 18052-3804
(610) 434-4294
FAX: (610) 439-1224
Department of Medicine
Division of General Internal Medicine
Provisional Active
Kathleen 0. Ververeli, MD
Allentown Asthma and Allergy
(Dr. Israel)
1605 N. Cedar Crest Blvd.
Suite 605
Allentown, PA 18104-2304
(610) 820-9000
FAX: (610) 820-9078
Department of Pediatrics
Division of Allergy
Provisional Active

Address Change
Peter H. Goldman, MD
1251 S. Cedar Crest Blvd.
Suite208D
Allentown, PA 18103-6205

New Practice Affiliations

Leadership Appointments Department ofSurgery
Steven J. Lawrence, MD
Chief, Section of Foot and Ankle. Surgery
Robert D. Riether, MD
Director, Colon/Rectal Residency
Program

Allied Health Professionals
Appointment
Renee Weiss
Physician Extender
Technical
(Dr. Yeisley)

Address Change
Guila Glosser, PhD
Department ofNeurology- 3W Gates
University ofPennsylyania Medical
Center
3400 Spruce Street
Philadelphia, PA 19 I 04-4283
(215) 662-3371

Resignation
Mary Ellen Lynch, CNM
Physician Extender
Professional - CNM
(Hospital- Center for Women's
Medicine)

Matthew A. Kasprenski, MD
Oakwood Medical Center
951 N. Fourth Street
Allentown, PA 18102-1899
(610) 434-8801
Stephan R. Sher, DO
Lehigh Valley Family Health Center
1730 Chew Street
Allentown, PA 18104-5595

(610) 402-3500

)

FAX: (610) 402-3509
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P & T HIGHLIGHTS
The following action were taken at the February 21, 1996 Pharmacy and Therapeutics Committee Meeting -Maria Barr,
Pharm.D., BCPS, Barbara Leri, Pharm.D., Janine Barnaby, R.Ph., Man Mauro, R.Ph.

CALCITONIN- THE
"NOSE" HAVE IT!

Calcitonin-salmon nasal solution
(MiacalcinR) has been added to the
formulary for treatment of postmenopausal osteoporosis in women with
low bone mass or who cannot take
estrogens. It is similar to the calcitonin
injection, which is currently on formulary.
The most common side effects include
rhinitis, back pain, arthralgia, epistaxis
and headache. There is a potential allergic
reaction because calcitonin salmon is a
protein. There are some advantages over
the traditional subcutaneous injection.
They are improved patient acceptance,
decreased incidence of GI upset and no
adjustment in dosage in renal impairment.
P~tients will have to be taught the proper
technique when using the solution, if
initiated in the hospital.
The dosage is one spray to a single nostril
per day which delivers 200 iu/day. It is
recommended to alternate nostrils for the
daily dose. Each nasal spray bottle
contains a 2 week supply of drug. The
dispensing procedure for nasal calcitonin is
in the process of being outlined for
patients being initiated and discharged on
this therapy.
Cost Comparison:
Nasal calcitonin 200 iu/day = $20.80 (acquisition cost)
Subcutaneous calcitonin 50 iu/day = $24.00

"FAT-FREE"
AMPHOTERICIN B
REMAINS THE AMPHO B
OF CHOICE AT L VH:

Amphotericin B Lipid Complex injection
(AbelcetR) is a new lipid-drug suspension
of the antifungal amphotericin B. AbelcetR
was presented to P&T in February but was
not added to the formulary at this time.
The review of the medication is presented
for your information. AbelcetR is indicated
for the treatment of aspergillosis in
patients who are refractory to or intolerant
of conventional amphotericin B therapy.
AbelcetR is a complex of amphotericin B
and two phospholipids in a 1:1 drug-lipid
molar ratio. The lipid-stabilization of
amphotericin B accounts for the potential
for lower adverse effects and to increase
the amount of amphotericin B that can be
given in a single dose.

The major side effects associated with
AbelcetR are, as with regular amphotericin,
transient chills and fever during infusion of
the drug. Other side effects include:
headache, abdominal pain, hypotension,
nausea, vomiting, diarrhea,
thrombocytopenia (4%), anemia (4%),
leukopenia (4%), increased serum
creatinine ( 11-12%), renal failure (5 %) ,
hypomagnesemia, hypokalemia,
hypocalcemia. AbelcetR can increase some
lab values such as AST, ALT, alkaline
phosphatase, and BUN.
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The recommended adult and child dose is
5mg/kg/day given as a single infusion.
The infusion should be run at a rate of
2.5mg/kg/hr. The bag containing the
suspension will need to be shaken if the
infusion time is greater than two hours.
The fmal concentration of the I. V. solution
should be 1mg/ml. For patients with
cardiovascular disease and pediatric
patients a concentration of 2mg/ml may
be, utilized if necessary. AbelcetR may
only be mixed in 5% dextrose solution due
to stability reasons.
The advantages of amphotericin B in a
lipid complex is that it appears to be
associated with less nephrotoxicity.
AbelcetR is also an alternative for the
treatment of aspergillosis. A disadvantage
is a 30 fold increase in cost compared to
conventional amphotericin B. Also, there
is limited clinical data available to date,
regarding direct comparison of liposomal
amphotericin B with conventional
amphotericin B.
Cost Comparison Usual Adult Dose Cost/day 70Kg Pt
amphotericin B
Smg/kg/day
$472.50
Lipid Complex
(supplied as a single use only vial)
conventional
amphotericin B

0.7mg/kg/day

'$15.60

WARFARIN
ADMINISTRATIONEXCEPTION FOR 7A
DIALYSIS

Due to the dialysis schedules of patients
and the potential removal of medications
by dialysis, all QD medications are
administered at 1800. As a result, 7A will
be the exception to the new policy of
dosing warfarin at 1200.

)

THE SUBSTITUTION
LIST IS GROWING!
Drug Dispensed
verapamil SR
(CalanR SR)

Substituted for
verapamil SR
(VerelanR)

cefuroxime
(CeftinR) tabs

cefpodoxime
(Vantirf) tabs
loracarbef
(LorabidR) tabs
cefprozil (CefzilR)

NO PROBLEMS WITH
ZOLPIDEM (AMBIENR)
CRITERIA

Starting 10/5/95, the pharmacy
department, under the guidance of the P &
T Committee, initiated automatic
substitution of zolpidem with oxazepam
unless one of the following criteria were
met:
- Age > 65 years AND est. CrCI
< 30ml/min
-- Hypersensitivity to benzodiazepines
- COPD with C02 retention (pC02 >50)
- Continuation of home therapy
The results of the evaluation for the last 3
months reveals a decrease in the average
number of zolpidem patient~ from 37
patients/month to 16 patients/month. The
primary reasons for use of zolpidem are
continuation of home therapy (34%) and
age and renal dysfunction (34%).
Based on the continued use of this
medication and its overall decline in use
over the past 3 months within the
institution, zolpidem will remain on
formulary with the same guidelines for
use. If additional issues arise, the
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guidelines and its formulary status will be
addressed at that time.
Thanks to all for criteria input and
compliance!

FYI: DID YOU KNOW?
Organidin liquid and tablets used to
contain iodinated glycerol as its active
ingredient. Wallace Labs has since
changed the formulation to guaifenesin
(same as Robitussina). The pharmacy
department will dispense guaifenesin liquid
and tablets, whenever OrganidinR is
ordered. The iodinated glycerol
formulation will no longer be
manufactured.
For outpatients, it wll be more costeffective to obtain either the guaifenesin
liquid or tablets over-the-counter, rather
than writing a prescription for Organidin
NR (Newly Reformulated guaifenesin).

pt\22196.hi
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Ionized Magnesium: A New Assay
Magnesium is the fourth most abundant cation in the
human body and the second most plentiful cation
after potassium in body cells. The vast array of
magnesium functions all derive from two biochemical
reactions namely chelation with anionic ligands and
competition with calcium for binding sites on
membranes and proteins. Magnesium acts as a
cofactor to activate more than 325 enzyme systems
including 4 in the regulation of intermediate
metabolism, 7 glycolytic, 4 tricarboxylic acid cycle
and 12 photosynthetic enzymes. Within the nucleus
magnesium binds to DNA to stabilize chromatic
structure. By regulating RNA synthase and M-RNA
attachment to ribosomes, ionized magnesium (MgH)
ions are in control of cell growth, replication, and
membrane structure. At the cell membrane, MgH
regulates permeability, electrolyte flux and binding of
hormones.
However, magnesiums most important function is to
act as an essential cofactor in the ATP dependent,
ion shutUing Na/K pump which maintains sodium and
potassium gradients across cell membranes. In
addition the magnesium activation of ATP creates
and maintains a 10,000 fold intra to intercellular
calcium gradient Simply stated, magnesium is a
calcium antagonist where .a decrease in magnesium
would promote calcium movement into the cell
prolonging contraction with resulting hypertension,
cardiovascular, neuromuscular, psychiatric metabolic
abnormalities, while an increased magnesium would
have the exact opposite effect
)

magnesium is found in protein, about 5% is
complexed with ions such as citrate and/or
phosphate and the remainder approximately 60% is
in the free (ionized) state (Mg').
Due to advances in ion selective electrode
technology ionized magnesium (MgH) is now
available from Health Network Laboratories. At this
time it is part of our emergency whole blood profile
which is mos~y utilized by OR, ED and Trauma and
as an individually orderable test on heparinized whole
blood. Because MgH is a relatively new test, there
are not many papers correlating increased or
decreased values to specific disease states. By
ordering the test we would expect that the physician
would become as comfortable with interpreting MgH
as total magnesium and relating values to health or a
disease state.
The clinical justification for a MgH is that the literature
suggests that not only does total magnesium not
correlate with intracellular magnesium but that
intracellular magnesium measurements are more
reflective of the severity of a magnesium deficiency
than total serum magnesium. In contrast intercellular
MgH appears to be comparable in concentration to
excellular MgH. In addition the rapid transport of MgH
between the intracellular and extracellular reservoirs
is consistent with a dynamic equilibrium. To
summarize, the extracellular MgH measurement
reflects the dynamic intracellular-intercellular
hemostasis and would be most likely to predict a
physiologic response.

The distribution of magnesium in serum is similar to
that of calcium. Approximately one third of
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Some diseases, clinical settings or syndromes resulting in abnormal magnesiums are listed below.

II

Hvoennaanesemia

Hvoomaanesemia
Reduced dietary intake

Renal failure

Hyperalimentation

Mg containing drugs

Alcoholism

Mg treatment for eclampsia

Malabsorption

Acidemia

Renal loss diaeresis, diuretics

Ad.disons hypothyroidism

AMI
CHF
Cardiac Surgery
Head Injury
Migraine Headache
Other Electrolyte Imbalance
Preeclampsia/Eclampsia
Hypertension
Digoxin Toxicity
Cyclosoorine transplant
Diabetic keto acidosis
Hyperthyroidism
Hyperparathyroidism
Surgery

Finally it is important to note that the recommended
daily requirement for magnesium is 350 mg/day.
Today a typical daily intake indicates a dietary
shortfall of 90-180 mg/day in this country. It is
interesting to note that strict vegetarians exhibit
significanHy decreased incidencies of ischemic heart
disease, sudden cardiac death, and hypertension and
they generally have above average dietary
magnesium intakes.

Please address any questions or concerns regarding
this issue to John J. Shane, MD, Chairperson,
Department of Pathology, at 402-8152, or Gerald E.
Clement PhD, Technical Director, Clinical
Laboratories, at 402-2534.
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Health Sciences Library
Computer Learning Resources
April, 1996

Saving your search in OVID
Do you have a search that you do on
a regular basis? Have you ever.spent hours
doing a complex search only to be caUed
away on an emergency? Well, don't loose
the information you've just obtained, save it.
To save your search strategy, you
need to be at the main screen, the one which
displays your search strategy. From this
screen, type <CTRL>B, for save, and select
Save Strategy. Here, you will be prompted
for a name, a comment, and if this should be
a temporary or permanent save. Temporary
saves are automatically deleted every 24
hours, permanent saves are not.
All saved strategies are stored in the
same location. If the name you have chosen
is already in use, a message will be displayed.
Simply choose Cancel and save your
strategy using a different name. A comment
will help differentiate your strategy from
others with a similar name.
To retrieve your strategy, again from
the main screen, type <CTRL>F, for .file,
choose Open from the file menu, and choose
Open Strategy. A list of all saved strategies
will be displayed. Simply use your arrow
keys to locate your strategy and press
<ENTER>.

Micromedex Update. ..
A problem has been discovered when
from some areas ofMicromedex.
After printing, the screen fills with
unreadable characters. Even though the item
you selected will print out normally, how
you continue is not very obvious.
printi~g

)

If this does happen to you, to refresh
the screen, you will need to type <ESC>X.
This command will take you back to the
previous menu and will refresh your screen.
Micromedex has been made aware of
the problem and is working on a solution
that should evident in the near future.

OVID Update. ..
When to use which OVID icon:
The only difference between the
icons is where they print.
OVID: This icon will print from all
hospital workstations, if not, contact the I/S
help desk at 8303.
OVID_Term: This icon is for use
only on systems with a locally attached
printer, i.e. your office computer. However,
both your computer and your LVH_Net
login must be specifically configured. If in
doubt, use the OVID icon.

* As we mentioned last month, the

Ovid full text Biomedical Collection has
arrived and should be available after March
20, 1996.

Suggestions and ideals are
always welcome. Ifyou would like to see
a particular topic addressed, please
contact Sherry Giardiniere, ext. 8406, or
Christopher Sarley, ext. 1641. Both are
available via E-mail.
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HEALTH SCIENCES LIBRARY
COMPUTER LEARNING RESOURCES
TRAINING WORKSHOPS
Apri/1996
All workshops are hands-on. Call the
Library at 402-8410 to register.
All applications are available via the
hospital network and you are required to
have the icons available to you when you
sign onto the network.

Internet- a little more WWW
Keep in mind that internet addresses change
conStantly. What works today may not work
tomo"ow!

MedWeb
http://www.cc.emory.edu!WHSCVmedweb.htm/

INTRODUCTION TO OVID,
MICROMEDEX, OPAC, INTERNET. ••
Monday, Apri/15, 10:00AMto 12:00 Noon
Monday, Apri/29, 10:00 AM to 12:00 Noon
Location: Information Services Classroom,
4th Floor, Cancer Center

This workshop will cover the basic functions
of each of the applications and how their
usage can best be integrated into our daily
job functions. Included will be an overview
of the OVID databases, Micromedex Drug
Interactions, how to use the automated card
catalog (OPAC), and an introduction to the
biomedical information available on internet.
MEDLINE (OVID)
Tuesday, April 2, 1:30- 3:30PM
Wednesday, Apri/3, 9:30-11:30AM
Tuesday, Apri/9, 1:30-3:30 PM
Wednesday, Apri/10,.9:30-11:30AM
Tuesday, Apri/23, 1:30-3:30 PM
Wednesday, Apri/24, 9:30-11:30 AM
(inform~l 2-3 people)
Location: Cedar Crest Library

Basic overview of the OVID interface will be
covered. When to use the OVID and
OVID Tenn icon, basic searching skills
includ~g Subject, Textword, Limiting,
combining, view. Printing and Saving,
Retrieving a Saved Search.

This site provides hundreds of links
to Biomedical Internet Resources.
Information includes textbooks, case studies,
patient information, and more
Association of American Medical Colleges
http:!lwww.aamc.org

The Association of American
Medical Colleges has a new Web Site
available with information regarding many
different subjects relating to healthcare,
teaching hospitals, medical education and
current medical news and events. It could be
extremely helpful to those of us involved in
Medical Education at LVH.
Medconnect
http:/lwww.medconnect.com

Provides a variety of programs for
the physician including board review
programs, case reviews, and medical news.
(even includes an internet tutorial)
Health Touch
http:!lwww.healthtouch.com

This particular site is intended for the
consumer providing information on many
health topics and diseases. It also contains a
medication guide on drug uses, precautions,
and side effects.
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Documentation transition to managed care
As health care becomes a managed care environment, we physicians need to realize managed
care's basic documentation tenets differ from
those of fee-for-service medicine. That means we
need to change the way we document patient
care in the medical record.

)

In a true managed care environment based on
capitation, not all members are patients. The
covered lives, to use a managed care term, actually
consist of three sets-the well, the early sick, and
the very sick. In this environment, cost management is the major driving economic force. (No matter
the reimbursement method, excellent care of the
patient is still the prime directive of our profession.)

2. For the early and very sick, include:
• medical necessity,
• medical appropriateness,
• informed consent and alternative treatment
options, and
• outcomes measurement and patient satisfaction.

Managed care includes sick and well

Today's records fail

In the managed care environment, the medical
record must document appropriate care and
evaluation of all patients as weB as good
treatment of the early and very sick.

Although it is conceivable that such a system could
be developed in a paper en\'ironment, the system
features described above are best developed as a
major component of a standardized, computerized health information management system.

The task, therefore, is monitoring healthy people
who are in need of sqeening, education, vaccination, routine preventive care, and early diagnostic testing, along with providing good documentation of treatment and follow-up for illness and
injury. Thus, practice guidelines will become a
key component of the medical record, rather
than only an intermittent component.
What to include in the record

The medical record under managed care will
have at least the following two components:

)

1. For all patients-practice guidelines for
wellness status and illness prevention, including:
• age/sex health screening, testing, and treatment;
• predisposed conditions, evaluations, and
management;
• covered/noncovered services and proven and
unproven treatments; and
• outcomes measurement and patient satisfaction.

There are practical implications for physicians
who are still documenting their patient interactions in their own handwriting.
For generalists or primary care providers using
paper records, the record should document:
• general health and preventive measures in one
section of the record; and
• individual problems, diagnoses, and treatments-similar to problem lists-in another
section of the record.

MRB, P.O. Box 1168, Marblehead, MA 01945. Telephone 617/639-1872. Fax 617/639-2982.
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For specialists using paper or electronic records,
the record should include only the details of care
outlined above for the early and very sick.

The following items were contributed by
MRB's sister publication Briefings on Practice Management.
Medicare HMO enrollees get POS option
The Health Care Financing Administration
(HCFA) will permit health maintenance
organizations (HMOs) to offer "point-:ofservice" (POS) benefits to Medicare recipients. A POS benefit allows HMO members to
seek care outside the provider network. The
patient pays a higher amount for the out-ofnetwork physician's services.
According to the HCFA guidelines, Medicare
managed care plans with risk-based contracts may offer a POS benefit. Medicare pays
risk plans a fixed amount for each enrollee,
and these plans assume all the financial
obligations of providing services to Medicare
beneficiaries through their provider networks.
Medicare will not make any additional
payments to plans that offer a POS benefit.
Questions about CLIA? Ask COLA
The Commission on Office Laboratory Accreditation (COLA) now has a free fax service to
answer questions about the Clinical Laboratory
Improvement Amendments of 1988 (CLIA).
To request information, call800/298-8044.
COLA has 33 fact sheets available on topics
such as state lab licensure laws, writing a
procedure manua~, registering a shared lab
with the Health Care Financing Administration (HCFA), CLIA inspection, and how to
respond after a CLIA survey. The COLA also
offers phone support for issues the fact
sheets don't cover.

Dean R. Backstrom, MD, is the author of A Minute
for the Medical Staff. He is a physician consultant
for Healthcare Miznagement Advisors in Alpharetta, GA.

HCFA's secondary-payer rule is final
The Health Care Financing Administration
(l-IeFA) has issued a secondary-payer rule
that forbids group health plans from offering
Medicare recipients different benefits than
they offer to other plan members. It also
prohibits employers from offering Medicareeligible employees incentives not to join the
company's health insurance plan.
HCFA doesn't want Medicare to become the
primary payer in cases in which it should be
the secondary payer of benefits. It will also
demand refunds on claims that Medicare
shouldn't have paid.
The rule was effective October 2, but HCFA
will enforce it retroactively to January 1987
for coverage of disabled people; to December
1989, for coverage of the elderly and beneficiaries with end-stage renal disease; and
August 1993, for failure of group plans to
refund mistaken Medicare payments.
HCFA may allow review requests by phone
Soon you may be able to receive faster reviews
on Part B initial claim determinations under
a rule proposed by the Health Care Financing
Administration (HCFA). The rule would allow
beneficiaries and providers to request reviews by telephone or electronic transmission.
Telephone review requests would not be
allowed, however, for determinations made
by peer review organizations (PROs) or
health maintenance organizations (HMOs).
For more information, contact Rosalind Little
of HCFA at 410/786-6972.

A Minute for the Medical Staff is an exclusive service for subscribers to Medical Records Briefing.
Reproduction ofA Minute for the Medical Staff is encouraged.
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Part I

FAIR HEARING AND APPELLATE REVIEW PROCESS

)

)
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FAIR HEARING ANP APPELLATE REVIEW PROCESS
SECTION !. • GENERAL TERMS.
A.

TITLE AND DEFINITIONS
1.

SHORT TITLE.
The Fair Hearing and Appellate Review Process shall be referred to herein as the Fair Hearing Plan or Plan.

2.

DEFINITIONS.
a.

Aopellate Revjew Body means the group designated under this Plan to hear a request for appellate review
properly filed and pursued by a Practitioner.

b.

~means the Board of Trustees of the Hospital. Provided, however, that in instances in which the "Board"

is charged with a certain function, duty or responsibility hereunder, nothing contained in this Plan shall preclude
the Board from delegating any such function, duty or responsibility to any committee of the Board.

B.

c.

Chjef Execytjye Offjcer !CEO! means the President of the Hospital or his or her designee.

d.

Hearjng Commjttee means the committee appointed under this Plan to hear a request for an evidentiary hearing
properly filed and pursued by a Practitioner.

e.

Joint Conference Commjttee means the Joint Conference Committee of the Board as that committee is defined
in the Hospital's Bylaws.

f.

Medjcal Execytjye Committee !MEC! means the Medical Executive Committee of the Medical Staff.

g.

Medjcal Staff means the Medical Staff of the Hospital.

h.

fA.I:lin

means the Practitioner who requested the hearing or appellate review and the body or bodies whose
adverse recommendation or action prompted the right to a hearing or appellate review under this Plan.

i.

Practitioner means the applicant or staff member against whom an adverse action has been recommended or
taken.

j.

Appeals Commjttee means the Appeals Committee of the Board as determined and appointed by the Chairpersor
of the Board of Trustees.

k.

Special Notjce means written notification sent by certjfjed or regjstered mail, return receipt requested.

INTERPRETATION
1. HEADINGS.
The Headings in this Plan are intended only for reference purposes and shall not be construed as defining, limiting
or describing the scope or intent of the Plan.
2.

NUMBERS.
As used in the Plan and required by context, each number (singular or plural) shall include all numbers.

3.

GENDER.
Whenever a personal pronoun is used, it shall mean a person of either gender.

SECTION II. • HEARING PROCESS.
A.

INITIATION OF HEARING.
1.

TRIGGERING EYENTS.

a. Recommendations or Actjons.
Except as otherwise set forth in the Bylaws, the following recommendations or actions, if deemed adverse under
Section II. A.1.b. below, entitle the Practitioner to a hearing upon timely and proper request:
( 1l

Denial of initial staff appointment; provided, however, that denial of initial appointment to the staff based upon
the requirements of the current Medical Staff Development Plan shall not entitle the Practitioner to a hearing;

{2)

Denial of reappointment;

{3)

Suspension of staff membership;
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)

(4)

Revocation of staff membership;

(5)

Denial of requested appointment to or advancement in staff category;

(6)

Reduction in staff category;

(7)

Suspension or limitation of the right to admit patients or of any other membership prerogative directly related
to the Practitioner's provision of patient care;

(8)

Denial of requested department (or service) or other clinical unit affiliation;

(9)

Denial or restriction of requested clinical privileges;

(10) Reduction in clinical privileges;
{11) Suspension of clinical privileges;
{12) Revocation of clinical privileges;
{13) Individual application of, or individual changes in, mandatory consultation requirement.
b.

When Deemed Adyerse.
A recommendation or action listed in Section II.A.1.a. is adverse only when it has been:
( 1)

Recommended by the MEC; or

(2)

Taken by the Board under circumstances where no prior right to request a hearing existed.

2. NOTICE OF ADYERSE RECOMMENDATION OR ACTION.
The CEO shall promptly provide the Practitioner with special notice of an adverse recommendation or action. The
notice to the Practitioner shall provide:
( 1)

that an adverse recommendation or action has been proposed to be taken against the Practitioner;

{2)

a summary of the reasons for the proposed recommendation or action;

{3)

that the Practitioner has the right to request a hearing on the proposed recommendation or action;

(4)

that the Practitioner has thirty (30) days after receiving the notice within which to submit a request for a hearing
and that the request must satisfy the conditions set forth in Section II.B.; and

(5)

a summary of the Practitioner's rights and duties pursuant to Section II.C.

A copy of the Medical Staff Bylaws and Fair Hearing and Appellate Review Process shall be included in the notice.
B.

REQUEST FOR HEARING.
1.

REQUEST FOR HEARING.
A Practitioner has thirty (30) days after receiving notice under Section II.A.2. to file a written request for a hearing.
The request must be delivered to the CEO either in person or by certified or registered mail. If the Practitioner intends
to be represented by an attorney at the hearing, the request for a hearing must state that intent and the name of the
Practitioner's attorney.

2.

FAILURE TO REQUEST HEARING.
A Practitioner who fails to request a hearing within the time and in the manner specified in Section II.B. 1. waives his
or her right to any hearing or appellate review to which he or she might otherwise have been entitled.

C.

PARTIES' RIGHTS AND DUTIES.
1.

)

RIGHTS Of·PARTIES. During a hearing, each party may:
cross-examint;~

a.

Call, examine, and

witnesses;

b.

Present evidence determined to be relevant by the Presiding Officer {as hereinafter defined), subject to Section
II.H.4. hereof;

c.

Request that the record of the hearing be made by the use of a court reporter;

d.

Request that copies of the said proceeding be available upon payment of any reasonable charges associated
with the preparation thereof; and

e.

Submit a written statement at the closing of the hearing.
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2.

3.

ADQITIONAL RIGHTS ANP DUTIES OF PRACTITIONER.
a.

Subject to Section II.B.1., the Practitioner may be accompanied and represented at the hearing by an individual
of his or her choice, including an attorney. The body whose recommendation or action prompted the right to
a hearing (as well as other interested committees or components of the Hospital, Board or Medical Staff) may
be represented by an attorney at the hearing if and only if the Practitioner is represented by an attorney. The
foregoing provision shall not be deemed to deprive the Practitioner or the body whose recommendation or actior
prompted the right to a hearing of the right to legal counsel in connection with the preparation for the hearing.

b.

Upon completion of the hearing, the Practitioner has the right to receive the written recommendation of the
Hearing Committee (as hereinafter defined).

c.

At least fifteen (15) days prior to a hearing, the Practitioner shall provide the body whose recommendation or
action prompted the right to a hearing with a list of witnesses. The parties shall also exchange exhibits at that
time and provide copies of the same to the Hearing Committee.

FAILURE TO APPEAR.
If the Practitioner fails, without good cause, to appear at the hearing, the right to a hearing and appellate review shall
be forfeited.

D.

NOTICE OF HEARING.
1.

NOTICE.
The CEO shall immediately deliver timely and proper hearing requests to the President of the Medical Staff or the
Chairperson of the Board depending upon whose recommendation or action prompted the right to a hearing. Upon
receipt of a request for a hearing, the President of the Staff or Chairperson of the Board, as appropriate, shall
schedule and arrange for a hearing which shall be not later than sixty (60) days from the receipt of the request for
the hearing. At least thirty (30) days prior to the hearing date, the CEO shall send the Practitioner special notice of
the time, place and date of the hearing and of the composition of the hearing panel; provided, however, that a hearing
for a Practitioner who is under suspension then in effect must be held as soon as the arrangements may be
reasonably made, but not later than forty-five (45) days after the CEO received the hearing request. The notice of
the hearing shall include a list of the witnesses (if any) expected to testify at the hearing on behalf of the body whose
recommendation or action prompted the right to a hearing.

E.

HEARING PROCEDURE.
1.

APPOINTMENT OF HEARING COMMITTEE.
a.

}

By the Medjcal Staff.
A hearing occasioned by an adverse MEC recommendation is conducted by a Hearing Committee appointed by
the President of the Medical Staff composed of at least three (3) members of the Medical Staff Permanent
Hearing Committee not in direct economic competition with the Practitioner involved. The President of the
Medical Staff shall designate one (1) of the appointees as Chairperson of the Hearing Committee.

b.

By the Board.
A hearing occasioned by an adverse action of the Board is conducted by a Hearing Committee appointed by the
Chairperson of the Board and composed of five (5) persons, including at least two (2) members of the Medical
Staff Permanent Hearing Committee, not in direct economic competition with the Practitioner. The Chairperson
of the Board shall designate one ( 11 of the appointees as Chairperson of the Hearing Committee.

c.

Servjce on Hearjna Commjttee.
(1)

(2)

A Medical Staff or Board member is not disqualified from serving on a Hearing Committee merely
because he or she participated in investigating the underlying matter at issue or because he or she has
hea~d of the case or has knowledge of the facts involved or what he or she supposed the facts to be.
A Medical Staff or Board member is disqualified from serving on a Hearing Committee if that Medical
Staff or Board member is in direct economic competition with the Practitioner.
If the Practitioner has any objection to the composition of the hearing panel, the same must be raised in
writing and delivered to either the President of the Medical Staff or the Chairperson of the Board, as
appropriate, at least ten ( 10) days prior to the scheduled date of the hearing. The Practitioner's objection
must state in sufficient detail the reasons and basis for the objection so made. The President of the Medical
Staff or the Chairperson of the Board, as appropriate, in his or her sole discretion, will take action upon the
objection. Action upon the objection may consist of the following: overruling the objection and proceeding
with the hearing on the scheduled date; sustaining the objection, replacing one or more of the Hearing
Committee members and proceeding with the hearing on the scheduled date; or sustaining the objection,
replacing one or more of the Hearing Committee members, and rescheduling the hearing for a date not later
than thirty (30) days from the date originally scheduled for the hearing.
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2. HEARING OFFICER/PRESIDING OFFICER.
a. Use of Hearjng Officer.
The use of a Hearing Officer to assist the Hearing Committee at the hearing is optional and is to be determined by
the President of the Medical Staff or the Chairperson of the Board, as appropriate. A Hearing Officer may or may
not be an attorney at law, but must be experienced in conducting hearings. A Hearing Officer shall not be in direct
economic competition with the Practitioner involved.
b. Presidjng Officer.
The Chairperson of the Hearing Committee or, in the Chairperson's discretion, the Hearing Officer, if any, shall be
the Presiding Officer. The Presiding Officer maintains decorum and assures that all participants have a reasonable
opportunity to present relevant oral and documentary evidence. The Presiding Officer shall determine the order
of procedure during the hearing and shall make all rulings on procedure and the admissibility of evidence. The
Presiding Officer may conduct pre-hearing conferences with the parties and is specifically empowered to impose
reasonable limitations, including time limitations, upo~ the parties and the presentation of their cases.
3. PERSONAL PRESENCE.
a. Failure to Aopear.
The personal presence of the Practitioner is required. A Practitioner who fails, without good cause, to appear and
proceed at the hearing waives his or her rights in the same manner as provided in Section 11.8.3.
b. Testjmony.
If the Practitioner does not testify in his or her own behalf, he or she may be called and examined as if undet crossexamination.
4. PROCEDURE AND EYIDENCE.
The hearing need not be conducted strictly in accordance with the rules of law relating to the examination of witnesses
or presentation of evidence. During a hearing, each party may present evidence determined to be relevant by the
Presiding Officer, regardless of its admissibility in a court of law. Furthermore, any relevant matter upon which
reasonable persons customarily rely in the conduct of serious affairs may be considered, regardless of the admissibility
of such evidence in a court of law. Each party is entitled, prior to or during the hearing, to submit memoranda
concerning any issue of law or fact, and such memoranda shall become part of the hearing record. The Presiding
Officer may, but is not required to, order that oral evidence be taken only on oath or affirmation administered by any
person designated by him or her and entitled to notarize documents in the state where the hearing is held or, if the
witness is unavailable, by affidavit.
·
5. OFFICIAL NOTICE.
In reaching a decision, the Hearing Committee may take official notice, either before or after submission of the matter
for decision, of any generally accepted technical or scientific matter relating to the issues under consideration and of
any facts that may be judicially noted by the courts of the state where the hearing is held. Parties present at the
hearing must be informed of the matters to be noticed, and those matters must be noted in the hearing record. Any
party shall be given opportunity, on timely request, to request that a matter be officially noticed and to refute any
officially noticed matter by evidence or by written or oral presentation of authority, in a manner to be determined by
the Hearing Committee. The Hearing Committee is also entitled to consider all other information that can be considered
under the Medical Staff Bylaws in connection with credentials matters.
6. BURDEN OF PROOF.
The body whose adverse action or recommendation prompted the right to a hearing has the burden of proof by clear
and convincing evidence, in support thereof.
7. HEARING BECOBQ.
A court reporter shall be utilized to prepare a record of the hearing.
8. POSTPONEMENT.
Request for postponement of a hearing may be granted by the Hearing Committee only upon a showing of good cause
and only if the request is made as soon as reasonably practicable.
9. PRESENCE OF HEARING COMMITTEE MEMBERS.
A majority of the Hearing Committee, but not less than three (3) members, must be present for each hearing and during
deliberations on the decision.

)
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10. RECESSES ANO APJOURNMENT.
The Hearing Committee may recess and reconvene the hearing without additional notice for the convenience
of the participants or for any other purpose. Upon conclusion of the presentation of oral and written
evidence, the hearing shall be closed. The Hearing Committee, shall at a time convenient to itself, conduct
its deliberations outside the presence of the parties. Upon conclusion of its deliberations, the hearing shall
be adjourned.
11. HEARING COMMITTEE REPORT.
Within ten ( 10) days after final adjournment of the hearing, the Hearing Committee shall make a written report
of its findings and recommendations and forwards the report along with the record and other documentation
to the body whose adverse action prompted the right to a hearing to the Practitioner involved and to the CEO.
The Hearing Committee Report shall include a statement of the basis for the recommendations or action.
12. RECONSIPERATION.
Upon written request of either party, the Hearing Committee shall have the right, in its sole and absolute
discretion, to re-open a hearing prior to the issuance of a Hearing Committee Report or to reconsider the
decision set forth in the Hearing Committee Report, if new and additional information is available. The
Hearing Committee shall not re-open a hearing or reconsider a decision based upon new and additional
information unless the party seeking to introduce the information can demonstrate that the information was
not available or discoverable in time for presentation to the Hearing Committee at the original hearing.·

F.

EFFECT OF HEARING COMMITTEE REPORT.
1. ACTION ON HEARING COMMITTEE REPORT.
Within thirty-five (35) days after receiving the Hearing Committee Report, the body whose adverse
recommendation or action occasioned the hearing considers it, and affirms, modifies or reverses its
recommendation or action. It transmits the result to the CEO.

2. NOTICE AND EFFECT OF RESULT
a.~.

The CEO shall promptly send a copy of the result of the body affirming, modifying, or reversing the
recommendation or action taken by the Hearing Committee to the Practitioner by special notice, to the
President of the Staff, to the MEC and to the Board.
b. Effect of Favorable Result.
( 1)

By the Board.
If the Board's result under Section II.F.1. is favorable to the Practitioner, it becomes the final
·
decision of the Board.

(2)

By the MEC.
If the MEC result is favorable to the Practitioner, the CEO shall promptly forward it, together with
all supporting documentation, to the Board and the Board shall take action consistent with Section
II.F.3. of this Plan.

c.

Effect on Adverse Result.
If the result of the MEC or the Board under Section II.F.1. continues to be adverse to the Practitioner, this
special notice shall inform him or her of his or her right to request an appellate review as provided in
Section Ill. of this Plan.

3. BOARP ACTION AfTER FAVORABLE MEC RESULT.
a.~.

The Board shall, within thirty (30) days of receipt of a matter, render a decision.
b. Effect of Favorable Actjon.
If the Board's decision after a favorable MEC result is also favorable to the Practitioner, it becomes the
final decision of the Board.
c.

Effect of Adyerse Actjon.
If the Board's decision after a favorable MEC result is adverse to the Practitioner, the decision of the
Board shall not be considered final. The CEO shall submit the matter to the Joint Conference Committee
for further review and consideration. The Joint Conference Committee shall, within thirty (30) days after
receipt of a matter, submit its recommendation to the Board. The Board shall then render a final decision.
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d.~.

The CEO shall provide the Practitioner and the President of the Staff with notice of the recommendation
of the Joint Conference Committee and/or the action and/or final decision of the Board.
SECTION Ill.· APPELLATE REVIEW PROCESS.
A.

REQUEST FOR APPELLATE REVIEW.
1. REQUEST FOR APPELLATE REVIEW.
A Practitioner has thirty (30) days after receiving special notice under Section II.F.2.c. to file a written request
for an appellate review. The request must be delivered to the CEO in person or by certified or registered mail
and may include a request for a copy of the Hearing Committee Report and record and all other material, if
not previously forwarded, that was considered by the Hearing Committee. If the Practitioner wishes to be
represented by an attorney at any appellate review proceeding, the request for appellate review must state
that desire and the name of the Practitioner's attorney. ..
2. FAILURE TO REQUEST APPELLATE REVIEW.
A Practitioner who fails to request an appellate review within the time and in the manner specified in Section
III.A.1. waives any right to an appellate review to which he or she might otherwise have been entitled.

B.

NOTICE OF TIME AND PLACE FOR APPELLATE REVIEW.
1. NOTICE.
The CEO shall immediately deliver timely and proper requests for appellate review to the Chairperson of the
Board. Upon receipt of a request for appellate review, the Chairperson shall schedule and arrange for an
appellate review which shall not be later than sixty (60) days from the receipt of the request for appellate
review. At least thirty (30) days prior to the appellate review, the CEO shall send the Practitioner special
notice of the time, place, and date of the review and of the composition of the appellate·review panel.

C. APPELLATE REVIEW PROCEDURE.
1. APPELLATE REVIEW BOQy.
If a MEC recommendation occasions the appellate review, the Appeals Committee of the Board shall serve
as the Appellate Review Body. If a Board action occasions the review, the Joint Conference Committee shall
serve as the Appellate Review Body. The Chairperson of the Board shall designate one (1) of the appointees
as Chairperson of the Appellate Review Body.
2. NATURE OF PROCEEQINGS.
The proceedings conducted by the Appellate Review Body are a review based upon the hearing record, the
Hearing Committee Report, all subsequent results and actions, the written and/or oral statements, if any,
provided below, and any other material that may be presented and accepted under the appellate review
procedure.
3. HEARING OFFICER/PRESIDING OFFICER.
a.

Use of Hearjng Officer.
The use of a Hearing Officer to assist the Appellate Review Body at the appellate review is optional and
is to be determined by the Chairperson of the Board. A Hearing Officer may or may not be an attorney
at law·, but must be experienced in conducting hearings and similar matters. A Hearing Officer shall not
be in direct economic competition with the Practitioner involved.

b. Presjding Offjcer.
The Chairperson of the Appellate Review Body or, in the Chairperson's discretion, the Hearing Officer,
if any, shall be the Presiding Officer.
4. REPRiSENTAT!ON AT APPELLATE REVIEW.
If the Practitioner desires to be represented by an attorney at an appellate review appearance, his or her
request for the review pursuant to Section III.A.1. must declare his or her desire to be so represented. The
Appellate Review Body shall determine in its sole discretion whether to permit such representation. The body
whose recommendation or action prompted the right to a appellate review (as well. as other interested
committees or components of the Hospital, Board or Medical Staff) may be represented by an attorney at the
appellate review if and only if the Practitioner is represented by an attorney. The foregoing provision shall
not be deemed to deprive the Practitioner or the body whose recommendation or action prompted the right
to the appellate review of the right to legal counsel in connection with the preparation for the appellate
review.
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5. WRITTEN STATEMENTS
The Practitioner may submit a written statement detailing the findings of fact, conclusions and procedural
matters with which he or she disagrees and his or her reasons for such disagreement. This written statement
may cover any matters raised at any step in the hearing and appellate review process. The statement shall
be submitted to the Appellate Review Body and the body whose adverse action promoted the appellate review
through the CEO at least fourteen (14) days prior to the scheduled date of the appellate review, except if the
time limit is waived by the Appellate Review Body. A similar statement may be submitted to the Appellate
Review Body through the CEO by the body whose adverse action prompted the appellate review at least
seven (7) days prior to the scheduled date of the appellate review.
6. ORAL STATEMENTS.
The Appellate Review Body, in its sole discretion, may allow the parties or their representatives to personally
appear and present oral statements. Any party or representative appearing shall be required to answer
questions of any member of the Appellate Review Body.
7. POWERS.
The Appellate Review Body has all the powers granted to the Hearing Committee, and any additional powers
that may be reasonably appropriate to or necessary for the discharge of its responsibilities.
8. PRESENCE OF MEMBERS.
A majority of the Appellate Review Body must be present for each appellate review session and during
deliberations.
9. RECESSES ANP ADJOURNMENTS.
The Appellate Review Body may recess and reconvene the proceedings without additional notice for the
convenience of the participants or for any other purpose. At the conclusion of the oral statements, if allowed,
the appellate review shall be closed. The Appellate Review Body shall then, at a time convenient to itself,
conduct its deliberations outside the presence of the parties. The appellate review shall be adjourned at the
conclusion of those deliberations.
10.

CONSIDERATION OF NEW OR APPITIONAL MATTERS.
Upon written request of either party, the Appellate Review Body shall have the right, in its sole and absolute
discretion, to consider new and additional information. The Appellate Review Body shall not consider any
such new and additional information unless the party seeking to introduce the information can demonstrate
that the information was not available or discoverable in time for presentation to the Hearing Committee at
the original hearing.

D. APPELLATE REVIEW ACTION
1. ACTION TAKEN.
Within thirty (30) days of adjournment, the Appellate Review Body may affirm, modify or reverse the adverse
result or action, or in its discretion, may refer the matter back to the Hearing Committee for further review
and recommendation to be returned to it within twenty (20) days and in accordance with its instructions.
Within ten (10) days after receipt of such recommendation from the Hearing Committee the Appellate Review
Body shall take action.
a. Jojnt Conference Commjttee.
If the Joint Conference Committee acted as the Appellate Review Body, it shall. submit its
recommendation to the Board. The Board shall then render a final decision.
b. Aopeals Commjttee.
If the Appeals Committee acted as the Appellate Review Body, it shall submit its recommendation to the
Board. If the Board's action is consistent with the last recommendation of the MEC, the decision shall
be considered .final. If the Board's action is inconsistent with the last recommendation of the MEC, the
decision ·of the Board shall not be considered final and the CEO shall submit the matter to the Joint
Conference Committee for further review and co~sideration. The Joint Conference Committee shall,
within thirty (30) days of receipt of ~he matter, submit its recommendation to the Board. The Board shall
then render a final decision.
2. NOTICE OF ACTION TAKEN.
The CEO shall provide the Practitioner, the President of the Medical Staff, the MEC, the Appellate Review
Body and the Board with notice of the recommendation and/or action taken by the Appellate Review Body,
the Joint Conference Committee and the Board.
'

}
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SECTION IV.- MISCELLANEOUS.
A. MISCELLANEOUS.
1 NUMBER OF HEARINGS AND REYIEWS.
I

Notwithstanding any other provision of the Medical Staff Bylaws or of this Plan, no Practitioner is entitled as
a right to request more than one ( 1) evidentiary hearing and appellate review with respect to the subject
matter that is the basis of the adverse recommendation or action which prompted such right.
2. COMPLIANCE WITH BYLAWS.
The failure by the Hospital ,or any of its committees or components to meet the conditions described in this
Plan shall not, in itself, constitute a violation of any state or federal law or a deprivation of the Practitioner's
due process rights.

.

3. EXHAUSTION OF BEMEPIES.

If an adverse recommendation is made or action taken pursuant to Section !I.A. of this Plan, the Practitioner
must first exhaust the remedies afforded by the Medical Staff Bylaws and this Plan before resorting to legal
action. The fact that a Practitioner has exhausted the remedies afforded by the Medical Staff Bylaws and
this Plan shall not in any way suggest that any subsequent legal action is proper or appropriate.
4. GRAPHIC SUMMARY.
A graphic summary of the Fair Hearing and Appellate Review Process is attached hereto as Exhibit A. The
summary should be used for informational purposes only and should not be deemed to grant any additional
rights or impose any additional duties on the parties. In the event of any discrepancy between the Plan and
the graphic summary, the language and terms of the Plan shall control.

j
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